Overview
Tarek Mekhail is an Oncologist practicing medicine in Orlando, Florida.
Dr. Mekhail is highly rated in 131 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.
He is actively involved in clinical research, co-authoring 48 peer reviewed articles and participating in 9 clinical trials. Dr. Mekhail is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- PPO
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2501 N Orange Ave Ste 689, Orlando, FL 32804
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
AHMG Oncology And Hematology At Orlando
Guru Sonpavde is an Oncologist practicing medicine in Orlando, Florida. Dr. Sonpavde is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Orchiectomy, and Nephrectomy. Dr. Sonpavde is currently accepting new patients.
AdventHealth Medical Group Oncology & Hematology At Orlando
Mark Socinski is an Oncologist practicing medicine in Orlando, Florida. Dr. Socinski is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Socinski is currently accepting new patients.
Orlando Health Cancer Institute - Downtown Orlando
Dr. Jad Chahoud is the chief scientific and innovation officer with Orlando Health Cancer Institute, where he drives the organization's vision for research excellence and technology-enabled innovation. In this role, he leads strategic initiatives to advance clinical trials, strengthen research infrastructure and integrate cutting-edge technologies that position Orlando Health as a national leader in patient-centered care and scientific advancement. He also is a board-certified medical oncologist and expert in treating advanced genitourinary cancers. Dr. Chahoud is passionate about transforming research operations through AI-enabled clinical trial systems and expanding patient access to groundbreaking therapies across Florida. Dr. Chahoud's Training Dr. Chahoud received his medical training at Lebanese University in Beirut, Lebanon. He completed an internal medicine residency at the University of Texas Health Science Center in Houston and a hematology and medical oncology fellowship at the University of Texas MD Anderson Cancer Center in Houston. He also earned a Master of Public Health and Master of Health Administration (MPH-MHA) from the University of Texas. About Dr. Chahoud Dr. Chahoud is board certified in hematology, medical oncology and internal medicine by the American Board of Internal Medicine. His professional memberships include the American Society of Clinical Oncology, American Association of Cancer Research, European Society of Medical Oncology and Society for Immunotherapy of Cancer. A nationally recognized clinician, scientist and expert in advanced genitourinary cancers, Dr. Chahoud has led numerous first-in-human and investigator-initiated studies and is internationally known for his research on renal cell carcinoma and rare malignancies. His work has been published in numerous top-tier medical journals, including The Lancet, Journal of Clinical Oncology and Nature. Outside of work, he enjoys spending time with family. Dr. Chahoud is fluent in English, Spanish, French and Arabic. Dr. Chahoud is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Penile Cancer, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Penectomy, and Nephrectomy. Dr. Chahoud is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine - Hematology, and American Board Of Internal Medicine - Medical Oncology.
Frequently Asked Questions about Dr. Tarek Mekhail
How do I make an appointment with Dr. Tarek Mekhail?
You can book an appointment with Dr. Tarek Mekhail by calling their office at 754-255-6741. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Tarek Mekhail a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Tarek Mekhail is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Tarek Mekhail specialize in?
While Dr. Tarek Mekhail is a Oncology, they have specific expertise in Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Tarek Mekhail participate in research or clinical trials?
Yes. Dr. Tarek Mekhail has published 48 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Tarek Mekhail's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Tarek Mekhail accept my insurance?
Dr. Tarek Mekhail accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 754-255-6741 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EGFR Positive Lung CancerDr. Mekhail isElite. Learn about EGFR Positive Lung Cancer.
- Lung CancerDr. Mekhail isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Mekhail isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Familial Colorectal CancerDr. Mekhail isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Mekhail isDistinguished. Learn about Familial Pancreatic Cancer.
- GliomaDr. Mekhail isDistinguished. Learn about Glioma.
- Large-Cell Lung CarcinomaDr. Mekhail isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Mekhail isDistinguished. Learn about Lung Adenocarcinoma.
- Advanced
- Acute Hepatic Porphyria (AHP)Dr. Mekhail isAdvanced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Lymphoblastic Leukemia (ALL)Dr. Mekhail isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Mekhail isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Mekhail isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Mekhail isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Intermittent PorphyriaDr. Mekhail isExperienced. Learn about Acute Intermittent Porphyria.
- Acute Mountain SicknessDr. Mekhail isExperienced. Learn about Acute Mountain Sickness.
- Acute Myelomonocytic LeukemiaDr. Mekhail isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Mekhail isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adenoid Cystic CarcinomaDr. Mekhail isExperienced. Learn about Adenoid Cystic Carcinoma.